These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3880303)

  • 1. [Effect of changes in the temperature of dialysis fluid on the efficiency of peritoneal dialysis].
    Panasiuk E; Wankowicz Z; Biernacki A; Gałecki Z
    Pol Arch Med Wewn; 1985; 74(5-6):327-33. PubMed ID: 3880303
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of sodium nitroprusside, furosemide and dopamine on the efficiency of peritoneal dialysis].
    Panasiuk E
    Pol Arch Med Wewn; 1985; 74(5-6):316-26. PubMed ID: 3880302
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison of various pharmacologic and conventional methods of increasing the effectiveness of intermittent peritoneal dialysis. III].
    Grzegorzewska A
    Przegl Lek; 1988; 45(10):721-8. PubMed ID: 3244837
    [No Abstract]   [Full Text] [Related]  

  • 4. Peritoneal dialysis. Measuring the dose in PD.
    Bernardini J
    Nephrol News Issues; 2001 Jul; 15(8):50-1. PubMed ID: 12099230
    [No Abstract]   [Full Text] [Related]  

  • 5. Advancing fluid management in peritoneal dialysis.
    Collins A; Mujais S
    Kidney Int Suppl; 2002 Oct; (81):S1-2. PubMed ID: 12230475
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of loss of active heparin in the peritoneal cavity during intermittent peritoneal dialysis].
    Kuźniak J; Grzegorzewska A
    Pol Tyg Lek; 1992 Feb 3-10; 47(5-6):123-5. PubMed ID: 1437798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How peritoneal dialysis works.
    Kelley KT
    Nephrol Nurs J; 2004; 31(5):481-2, 488-9; quiz 490-1. PubMed ID: 15518250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of sulfinpyrazone on peritoneal and renal clearance in patients with chronic renal failure treated by intermittent peritoneal dialysis].
    Grzegorzewska A; Antoniewicz K; Kuźniak J; Zawadzka E
    Przegl Lek; 1990; 47(10):686-90. PubMed ID: 2089444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate clearance by high-flux hemodialysis and peritoneal dialysis: a case report.
    Murashima M; Adamski J; Milone MC; Shaw L; Tsai DE; Bloom RD
    Am J Kidney Dis; 2009 May; 53(5):871-4. PubMed ID: 19339090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The peritoneal equilibration test.
    Peritoneal Dialysis Special Interest Group
    Nephrol Nurs J; 2005; 32(4):452-3. PubMed ID: 16180789
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of injection Salvia miltiorrhizae on peritoneal dialysis].
    Xu ZC
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1993 Feb; 13(2):74-6, 67. PubMed ID: 8334340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of furosemide added to peritoneal dialysis fluid on hydroxyproline excretion in dialysate and urine].
    Sucharzewska-Tomczak M; Grzegorzewska A
    Przegl Lek; 1994; 51(7):300-2. PubMed ID: 7871203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. At-home dialysis: consider the advantages.
    Johns Hopkins Med Lett Health After 50; 2004 Nov; 17(9):3, 7. PubMed ID: 15609440
    [No Abstract]   [Full Text] [Related]  

  • 14. [Transperitoneal transport of water and substances--between theory and practice].
    Baczyński D; Antosiewicz S; Waniewski J; Marciniak M; Wańkowicz Z
    Pol Merkur Lekarski; 2006 Aug; 21(122):192-5; discussion 196. PubMed ID: 17144109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of pharmacologic agents on transperitoneal elimination of low-molecular compounds during peritoneal dialysis].
    Grzegorzewska A
    Pol Arch Med Wewn; 1989; 82(2-3):65-70. PubMed ID: 2638739
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of an L-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trial.
    Bonomini M; Di Liberato L; Del Rosso G; Stingone A; Marinangeli G; Consoli A; Bertoli S; De Vecchi A; Bosi E; Russo R; Corciulo R; Gesualdo L; Giorgino F; Cerasoli P; Di Castelnuovo A; Monaco MP; Shockley T; Rossi C; Arduini A
    Am J Kidney Dis; 2013 Nov; 62(5):929-38. PubMed ID: 23725973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyponatremia due to unopened septa of peritoneal dialysis fluid bags.
    Aoki Y; Inata Y; Nakano S; Yamamura N; Yamamoto K
    Pediatr Int; 2020 Jul; 62(7):878-879. PubMed ID: 32573040
    [No Abstract]   [Full Text] [Related]  

  • 18. Revisiting the peritoneal dialysis dose.
    Moran J; Correa-Rotter R
    Semin Dial; 2006; 19(2):102-4. PubMed ID: 16551285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dialysis: low-glucose-containing peritoneal dialysis solutions: good or bad?
    Jha V; Rathi M
    Nat Rev Nephrol; 2013 Nov; 9(11):635-6. PubMed ID: 24080795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combination of biocompatible peritoneal dialysis solutions and residual renal function, peritoneal transport, and inflammation markers: a randomized clinical trial.
    Lui SL; Yung S; Yim A; Wong KM; Tong KL; Wong KS; Li CS; Au TC; Lo WK; Ho YW; Ng F; Tang C; Chan TM
    Am J Kidney Dis; 2012 Dec; 60(6):966-75. PubMed ID: 22835900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.